Biliverdin reductase-A is a pleiotropic
enzyme involved not only in the reduction of
biliverdin-IX-alpha into
bilirubin-IX-alpha, but also in the regulation of
glucose metabolism and cell growth secondary to its
serine/
threonine/
tyrosine kinase activity. Together with
heme oxygenase, whose metabolic role is to degrade
heme into
biliverdin-IX-alpha, it forms a powerful system involved in the cell stress response during
neurodegenerative disorders. In this paper, an up-regulation of the
biliverdin reductase-A
protein levels was found in the hippocampus of the subjects with
Alzheimer disease and arguably its earliest form,
mild cognitive impairment. Moreover a significant reduction in the phosphorylation of
serine,
threonine and
tyrosine residues of
biliverdin reductase-A was found, and this was paralleled by a marked reduction in its
reductase activity. Interestingly, the levels of both total and phosphorylated
biliverdin reductase-A were unchanged as well as its enzymatic activity in the cerebella. These results demonstrated a dichotomy between
biliverdin reductase-A
protein levels and activity in the hippocampus of subjects affected by
Alzheimer disease and
mild cognitive impairment, and this effect likely is attributable to a reduction in the phosphorylation of
serine,
threonine and
tyrosine residues of
biliverdin reductase-A. Consequently, not just the increased levels of
biliverdin reductase-A, but also its changed activity and phosphorylation state, should be taken into account when considering potential
biomarkers for
Alzheimer disease and
mild cognitive impairment.